Contribution of Ayurvedic products to GDP

The statistical information about the total contribution of Ayurvedic healthcare and medicine manufacturing to the GDP is available in the form of percentage share of ayurvedic products in the GDP. GDP statement of pharmaceuticals, medicinal chemicals and botanical products along with percentage share of ayurvedic products to the GDP for the last five years is as below:

GVA at current prices in Crore of rupees.

Description	2011-12	2012-13	2013-14	2014-15	2015-16
Manufacture of pharmaceutical; medicinal chemicals and botanical products	90544	85609	101262	113354	126695
Total manufacturing	1409986	1572830	1713445	1883929	2065093
Share to total manufacturing	6.42	5.44	5.91	6.02	6.14
All India GDP	8106656	9205315	10366266	11470415	12451938
% share of contribution of ayurvedic products to GDP	1.12	0.93	0.98	0.99	1.02

GVA at constant prices in Crore of rupees.

Description	2011-12	2012-13	2013-14	2014-15	2015-16
Manufacture of pharmaceutical; medicinal chemicals and botanical products	90544	82439	95529	104877	116968
Total manufacturing	1409986	1493261	1573078	1683077	1863834
Share	6.42	5.52	6.07	6.23	6.28
All India GDP	8106656	8548229	9079250	9709347	10469720
% share of contribution of ayurvedic products to GDP	1.12	0.96	1.05	1.08	1.12

Sources: www.mospi.gov.in/ press release dated 31.01.2017

The National Medicinal Plants Board (NMPB) under Ministry of AYUSH, Government of India, since its inception in the year 2000, has been promoting cultivation of medicinal plants throughout the country. NMPB has supported cultivation of medicinal plants over an area of about 2,61,933 hectares in different states of the country. During the financial year 2016-17, cultivation of prioritized medicinal plant on about 12, 416 hectares of land has been supported through National AYUSH Mission, state-wise details of the area supported for medicinal plants cultivation are given below:

S. No.	Name of the State	Area of supported cultivation in Hectares
1.	Andhra Pradesh	1248
2.	Arunachal Pradesh	142.4
3.	Assam	261
4.	Chhattisgarh	220
5.	Gujarat	191.6
6.	Goa	22.5
7.	Haryana	245
8.	Himachal Pradesh	120
9.	Jammu & Kashmir	34
10.	Karnataka	735.46
11.	Kerala	535
12.	Madhya Pradesh	2518
13.	Manipur	242
14.	Meghalaya	48
15.	Mizoram	27
16.	Nagaland	138
17.	Orissa	488.504
18.	Punjab	360
19.	Puducherry	43
20.	Rajasthan	1162.5
21.	Sikkim	32
22.	Tamil Nadu	960
23.	Telangana	294.18
24.	Uttar Pradesh	1898
25.	Uttarakhand	220
26.	West Bengal	230
	Total	12416.144

With an objective to address quality issues of Ayurvedic and other such medicines, Government has taken following corrective measures-

i) Directive dated 14^th October, 2005 under the provisions of Section 33EEB of the Drugs & Cosmetics Act, 1940 was issued to make testing of heavy metals mandatory for export purposes in respect of every batch of purely herbal Ayurvedic, Siddha and Unani drugs by every licensee and to display on the container of export oriented products the words “Heavy Metals Within Permissible Limit” with effect from 1^st January 2006.

ii) GMP Guidelines for Rasaushdhies have been added in Schedule ‘T’ of the Drugs & Cosmetics Rules, 1945 since 9^th March 2009.

iii) Pharmacopoeia Commission of Indian Medicine & Homoeopathy has been established to develop standards of drugs and standard operating procedures of manufacturing Ayurvedic Drugs for publication of the respective pharmacopoeias.

iv) For facilitating export of Ayurvedic medicines, quality certification systems based on WHO Guidelines and International Standards are administered by Drugs Controller General and Quality Council of India respectively.

v) Central Pharmacopieal Laboratory of Indian Medicine, Ghaziabad (U.P.), 27 State Drug Testing Laboratories supported by the Central Government and 44 laboratories licensed under the provisions of Drugs & Cosmetics Rules, 1945 are in place to carry out testing of Ayurvedic drugs & raw materials.

vi) Financial support is provided through National AYUSH Mission to strengthen State pharmacies, Drug Testing Laboratories and Enforcement Framework.

vii) Provision has been made in the Central Sector Scheme of International Cooperation for the industry to avail financial support for preparation of technical dossiers and registration of AYUSH medicines in foreign countries to obtain market authorization.